AAMU
OPTN

Amundi Asset Management US’s OptiNose OPTN Stock Holding History

Amundi Asset Management US’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,920
Closed -$1.11K – 1676
2018
Q4 		$1.11K Buy
+11,920
New +$1.7M ﹤0.01% 1150

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amundi Asset Management US's OPTN Position: Q1 2019 in Review

Amundi Asset Management US sold out of OptiNose (OPTN) in Q1 2019, closing a stake of 11,920 shares — an estimated $1.11K sold.

Amundi Asset Management US first reported a position in OPTN in Q4 2018 and held it in 1 quarter. The position peaked at $1.11K in Q4 2018. 64 funds tracked by Wall St. Rank hold OPTN as of Q1 2019.

  • Amundi Asset Management US reported no remaining OptiNose position as of Q1 2019 after selling out during the quarter.
  • Amundi Asset Management US sold 11,920 OptiNose shares in Q1 2019, an estimated $1.11K.
  • Amundi Asset Management US first reported a position in OptiNose in Q4 2018 and held it in 1 quarter.
  • Amundi Asset Management US's OptiNose position peaked at $1.11K in Q4 2018.
  • 64 funds tracked by Wall St. Rank held OptiNose as of Q1 2019.

Based on Amundi Asset Management US's 13F filing for Q1 2019, filed 13 May 2019.